SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,585.79 |
| Enterprise Value ($M) | 5,049.80 |
| Book Value ($M) | 1,464.98 |
| Book Value / Share | 9.01 |
| Price / Book | 3.81 |
| NCAV ($M) | 897.91 |
| NCAV / Share | 5.52 |
| Price / NCAV | 6.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.20 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.81 |
| Current Ratio | 3.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,488.50 |
| Assets | 2,055.57 |
| Liabilities | 590.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,557.63 |
| Operating Income | 420.64 |
| Net Income | 367.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 439.12 |
| Cash from Investing | -111.31 |
| Cash from Financing | -494.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | 4.30 | -44.60 | |
| 13G | Price T Rowe Associates Inc /md/ | 7.90 | 727.77 | |
| 13G/A | Vanguard Group Inc | 11.52 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 248,006 | 1,317,185 | 18.83 | |
| 426,392 | 1,423,811 | 29.95 | |
| 203,841 | 1,126,305 | 18.10 | |
| 232,076 | 992,573 | 23.38 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGIO – Agios Pharmaceuticals, Inc. | AKRO – Akero Therapeutics, Inc. |
| ALEC – Alector, Inc. | ALLK – Allakos Inc. |
| ALLO – Allogene Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io